If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.50 (0.69%)
Bid:
72.00
Ask:
73.00
Spread: 1.00 (1.389%)
Market Cap: £342.04m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Contracts round-up: GETECH, Norcon, Avacta

Mon, 24th Sep 2012 09:41
GETECH, the oil services business specialising in the provision of exploration data and geological exploration studies, has announced a new call-off contract, valued at one million euro, with a major existing client. The order includes a committment to GETECH's Global Programmes, as well as purchase of its Trident gravity dataset. The client is the seventh to sign up to the core elements of GETECH's CryoSat research project, which is a pilot study aimed at improving the exploration value of satellite gravity data. Avacta Group, which provides analytical and diagnostic technologies and services to the pharmaceutical and animal healthcare sectors, has signed its third agreement with Pall Corp, which will sell and distribute Avacta's protein drug development tool, known as Optim, in India. Norcon, the global communications network specialist, has confirmed that the large new project secured in Indonesia, announced last week, is with Indosat. The project is to enhance, expand and improve the quality of Indosat's cellular network. "Diversification of our revenue base into new geographies is the key strategic priority for Norcon and this deal with Indosat is evidence that we are making progress here," the firm's acting CEO said. NR

Related News

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta hails "strong progress" in first half of 2026
22 Jun 2026

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

Avacta Group News

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta hails "strong progress" in first half of 2026
22 Jun 2026

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

IN BRIEF: Avacta Group raises GBP9 million for bond repayments
5 Jun 2026

IN BRIEF: Avacta Group raises GBP9 million for bond repayments

Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional inve...

Avacta to reduce convertible bond debt after £9m placing
5 Jun 2026

Avacta to reduce convertible bond debt after £9m placing

(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and exi...

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value
29 May 2026

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

Avacta strengthens oncology position in 2025
19 May 2026

Avacta strengthens oncology position in 2025

(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, w...